The CAV1 Knockout HAP1 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal cell population in which the CAV1 gene has been disrupted to ablate caveolin-1 function. This polyclonal format comprises a heterogeneous pool of HAP1 cells harboring diverse editing outcomes at the CAV1 locus, providing a robust loss-of-function model that avoids clonal bias and mimics heterogeneous cellular responses. The cells are designed for researchers investigating caveolin-1 biology and its role in membrane architecture, signal transduction, and lipid homeostasis.
HAP1 is a near-haploid human cell line derived from the KBM-7 chronic myeloid leukemia cells, possessing a single copy of most chromosomes. This genetic simplicity makes HAP1 an exceptional platform for CRISPR/Cas9-mediated knockout studies, as disruption of a single allele often yields a complete loss-of-function phenotype. The cell line is widely adopted for functional genomics, haploid genetic screens, and signaling research due to its stable near-haploid state and male karyotype.
CAV1 encodes caveolin-1, the principal structural protein of caveolae, which are flask-shaped plasma membrane microdomains. Caveolin-1 functions as a scaffolding protein by binding and inhibiting multiple signaling kinases through its caveolin-scaffolding domain, including SRC, EGFR, and eNOS (NOS3). Caveolin-1 is transcriptionally regulated by factors such as FOXO1/3, PPARG, SREBP1, and EGR1, and its expression is modulated by TGFB1, insulin, and oxidative stress. At the protein level, caveolin-1 interacts with CAV2 and PTRF/cavin-1 to form stable caveolar complexes. Downstream, caveolin-1 suppresses eNOS activity, inhibits SRC kinase, modulates EGFR activation, and regulates Ras-MAPK and TGF?? signaling pathways. Thus, CAV1 disruption removes a critical brake on key oncogenic and metabolic signaling cascades.
In the HAP1 near-haploid background, CAV1 knockout directly eliminates caveolin-1 expression, leading to caveolae disruption and unchecked activation of associated kinases. This polyclonal cell pool is particularly suited for bulk biochemical and phenotypic assays, as it encompasses a range of genetic disruptions that collectively represent the null phenotype while mitigating the risk of clonal artifacts. The model facilitates investigations into caveolae-mediated endocytosis, cholesterol homeostasis, and the interplay between membrane trafficking and signal transduction. Given caveolin-1??s role in diseases such as breast and prostate cancer, lipodystrophy, and pulmonary arterial hypertension, this tool enables mechanistic studies linking gene dosage and pathway dysregulation.
Primary applications include immunoblotting for caveolin-1 and its interacting partners (CAV2, PTRF), immunofluorescence visualization of caveolae, and quantitative assays for EGFR phosphorylation, eNOS activity, and cholesterol uptake. Functional studies may involve migration and invasion assays, flow cytometry for surface receptor levels, and co-immunoprecipitation. These assays enable systematic dissection of CAV1-dependent signaling networks. For additional information, contact Ascent Research.
